Konsulentfirmaet LG Pharma ApS: Financial statements 2025
CVR: 44845016
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Konsulentfirmaet LG Pharma ApS (CVR 44845016) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 960,214 and a net result of DKK 160,802 compared with DKK 18,306 the year before. That is an increase of 25% compared with the year before. Equity in the 2025 report amounted to DKK 512,108. The solvency ratio was 50%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 960,214
- Profit/Loss
- DKK 160,802
- Equity
- DKK 512,108
- Total Assets
- DKK 1,023,498
- Employees
- 1
Official annual report
How creditworthy is Konsulentfirmaet LG Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Konsulentfirmaet LG Pharma ApS has published its annual report for 2024. Gross profit came to DKK 768,170, and the net result was DKK 18,306.
About Konsulentfirmaet LG Pharma ApS
Konsulentfirmaet LG Pharma ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 2024. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Liselotte Gothenborg Schougaard. The company is owned by Liselotte Gothenborg Schougaard. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 960,214 and a net result of DKK 160,802 compared with DKK 18,306 the year before. Equity in the 2025 report amounted to DKK 512,108.